Home Synthekine

Synthekine

In operation
Series C
Targeted Cytokine Therapeutics Developer

Basic Information

Synthekine is a developmental-stage biologics company engineering novel specificity, selectivity, and potent cytokine therapies. Guided by their deep expertise in immunology, their targeted protein engineering delivers transformative immunotherapies for the treatment of cancer and autoimmune diseases.
Synthekine
California,United States of America
15~50 people
January 01, 2018
--